CO-WESTERN-UNION
Western Union (NYSE:WU), a global leader in cross-border, cross-currency money movement and payments, and Cebuana Lhuillier , the largest and long-tenured microfinancial service provider in the Philippines, have come together to enable customers in the Philippines to send and receive Western Union money transfers.
The significant collaboration with Cebuana Lhuillier adds 2,500 more locations to Western Union’s global network and will provide greater access to customers in the world’s fourth largest remittance receiving country. Money transfer customers accessing Cebuana Lhuillier’s nationwide branch network will be able to send or receive money via Western Union’s global network in more than 200 countries and territories. The services are expected to be rolled out in the coming weeks.
“Western Union and Cebuana Lhuillier understand the importance of connectivity and building relationships, while keeping customers at their core. This strategic collaboration and integration of capabilities of two leaders highlights the power of combined assets to meet customer’s needs,” said Jean Claude Farah , President, Global Network, Western Union.
Farah added, “In an age when speed, reliability and convenience mean everything, we are increasing the number of touchpoints where our customers can access our services and connect with their loved ones around the world. We welcome Cebuana Lhuillier to the Western Union family and are proud and excited to work collaboratively to reach more customers together.”
After successfully serving Filipinos for decades offering vital financial services, the two companies have joined forces to advance cross-border money movement for customers in the Philippines. This alliance supports Western Union’s strategy to leverage its platform and portfolio of capabilities, enabling other businesses looking to expand their global reach and build upon a robust partnership. The cooperation between the two companies also puts forward Cebuana Lhuillier’s vision of empowering Filipinos through financial services.
“This partnership with Western Union is a prudent step in ensuring accessibility for the millions of Filipinos around the world and in paving the way for a future-proof network with presence in almost all parts of the globe,” said Jean Henri Lhuillier, President and CEO of Cebuana Lhuillier.
“We are more than thrilled to collaborate with Western Union as their company values line up perfectly with our core of facilitating financial inclusion for the underserved Filipinos and expanding our reach makes that all the more possible,” added Lhuillier.
Cebuana Lhuillier is a one-stop shop that offers microfinancial services to over 30 million clients through its more than 2,500 branches with 20,000 domestic partners and 1.7 million physical and virtual touchpoints. The company is also acting as a cash agent for Cebuana Lhuillier Rural Bank and has since provided a bank account to 4 million previously unbanked Filipinos since the launch of the rural bank’s revolutionary product Cebuana Lhuillier Micro Savings.
Western Union serves customers globally from a fast-growing digital network of web, app, and the largest Agent retail locations across the world. In addition, Western Union’s global payout network includes billions of bank accounts and wallets offering unparalleled convenience to families and loved ones sending money to the Philippines. In the Philippines, customers will soon be able to send and receive through Cebuana Lhuillier and may check the Agent Locator link for the status of their nearest locations.
About Western Union
The Western Union Company (NYSE: WU) is a global leader in cross-border, cross-currency money movement and payments. Our omnichannel platform connects the digital and physical worlds and makes it possible for consumers and businesses to send and receive money and make payments with speed, ease, and reliability. As of March 31, 2020, our network included over 550,000 retail agent locations offering our branded services in more than 200 countries and territories, with the capability to send money to billions of accounts. Additionally, westernunion.com , our fastest growing channel in 2019, is available in over 75 countries, plus additional territories, to move money around the world. With our global reach, Western Union moves money for better, connecting family, friends, and businesses to enable financial inclusion and support economic growth. For more information, visit www.westernunion.com .
About Cebuana Lhuillier
P.J. Lhuillier, Inc. (PJLI) is the proud parent company of Cebuana Lhuillier, the Philippines’ largest microfinancial services provider that offers pawning, remittance, micro insurance, bills payment, e-load, business-to-business solutions services, and micro savings and other banking services through their banking arm, the Cebuana Lhuillier Rural Bank. For more than 30 years, Cebuana Lhuillier continuously provides fast, easy, secure, and convenient microfinancial products and services to more than 30 million customers through over 2,500 branches nationwide. The company has also expanded its services into the digital space through the eCebuana App, a product of the Cebuana Lhuillier Rural Bank, and a host of other financial platforms such as Cebuana From Home, ProtectNow.com and the Cebuana Lhuillier Jewelry website.
Cebuana Lhuillier is committed to its purpose of bringing financial inclusion to the majority of Filipinos and has remained at the forefront of its industry through its many product innovations and leadership in customer service. Its commitment to excellence has given rise to many countless accolades and recognitions here and abroad.
WU-G
View source version on businesswire.com: https://www.businesswire.com/news/home/20200728005065/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
TII Launches Falcon Reasoning: Best 7B AI Model Globally, Also Outperforms Larger Models5.1.2026 14:54:00 CET | Press release
Falcon H1R 7B Packs Advanced Reasoning into a Compact 7 Billion Parameter Model Optimized for Speed and Efficiency TII’s Latest AI Model Outperforms Larger Rivals from Microsoft, Alibaba, and NVIDIA on Key Benchmarks The Technology Innovation Institute (TII), the applied research pillar of Abu Dhabi’s Advanced Technology Research Council (ATRC), has announced the release of Falcon H1R 7B, a next-generation AI model that takes a significant step toward making advanced AI more accessible than ever, by delivering world-class reasoning performance in a compact, efficient, and openly available format. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260105981339/en/ TII Launches Falcon Reasoning: Best 7B AI Model Globally, Also Outperforms Larger Models (Graphic: AETOSWire) With just 7 billion parameters, Falcon H1R 7B challenges and, in many cases, outperforms larger open-source AI models from around the world, including models fr
Curing the Incurable with ‘Biological Age Zero’ Cells: Clonell™ Launches the Ultimate Regenerative Medicine Platform5.1.2026 14:00:00 CET | Press release
Fundamental Cure for Intractable and Incurable Diseases using ‘Biological Age Zero’ Cells Derived from Patient’s Own Cells via SCNT TechnologyWorld's First Therapy Platform Simultaneously Solving Immune Rejection and Inheritance of Cellular Aging—The Major Hurdles of Existing Stem Cell TherapiesDrastically Improving Treatment Accessibility through the New Paradigm, ‘Patient-Initiated Clinical Trial™’, which Overcomes Existing Clinical Limitations Clonell Therapeutics, Inc., a leading biotechnology company dedicated to curing intractable and incurable diseases, announced today the official launch of the world's first 'Patient-Specific Embryonic Stem Cell (Somatic Cell Nuclear Transfer-derived Embryonic Stem Cell, hereinafter SCNT-ESC)' therapy platform based on Somatic Cell Nuclear Transfer (SCNT) technology. Concurrently, the company has initiated its innovative 'Patient-Initiated Clinical Trial™' to apply this breakthrough technology directly to patients. This platform launch is evalu
HELUS Pharma Propels Therapeutic Innovation in Mental Health and Commences Trading on Nasdaq5.1.2026 13:30:00 CET | Press release
Helus Pharma builds on the strong foundation originally created as Cybin Inc., reflecting the Company’s ongoing transformation to a commercial stage pharmaceutical company Helus Pharma commences trading on Nasdaq Global Market (“Nasdaq”) and on Cboe Canada under ticker symbol: HELP Helus Pharma continues to progress its portfolio of novel serotonergic agonists (“NSAs”), with the goal of developing treatments designed to redefine mental health care, including HLP004 for the treatment of generalized anxiety disorder, with Phase 2 topline data readout expected in Q1 2026 Preparations in progress for the commercialization of HLP003, Helus Pharma’s NSA in Phase 3 clinical development, which has been granted Breakthrough Therapy Designation by the FDA for the adjunctive treatment of major depressive disorder This news release constitutes a “designated news release” for the purpose of the Company’s prospectus supplement dated December 30, 2025, to it short form base shelf prospectus dated Sep
Incyte Announces Positive Topline Results from Pivotal Study of Tafasitamab (Monjuvi®/Minjuvi®) as a First-line Treatment for Diffuse Large B-Cell Lymphoma5.1.2026 13:30:00 CET | Press release
- Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP met its primary endpoint of progression-free survival (PFS) - Based on these results, Incyte plans to file a supplemental Biologics License Application (sBLA) for tafasitamab and lenalidomide in addition to R-CHOP in first-line diffuse large B-cell lymphoma (DLBCL) in the first half of 2026 Incyte (Nasdaq:INCY) today announced positive topline results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19 targeting monoclonal antibody, and lenalidomide in addition to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone) compared to R-CHOP alone as a first-line treatment for adults with newly diagnosed diffuse large B-cell lymphoma (DLBCL) with an International Prognostic Index (IPI) score of three to five (3-5) for patients >60 years o
SBC Medical Accelerates Global Expansion with Strategic Investment and Alliance witha Leading U.S. MedSpa Platform OrangeTwist as Part of Broader Growth Strategy5.1.2026 13:00:00 CET | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services to medical corporations and their clinics, today announced the completion of a strategic minority equity investment and the establishment of a structured collaboration framework with OrangeTwist, a leading U.S.-based MedSpa chain, alongside its longstanding institutional shareholders, Hildred Capital and Athyrium Capital. This transaction marks SBC Medical’s formal entry into the United States—a key global market for medical aesthetics—and represents a major milestone in the Company’s broader global expansion strategy. For more details, click here. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251210926005/en/ OrangeTwist Supporting 258 affiliated clinics worldwide and managing more than six million patient visits annually, SBC Medical has built one of the largest and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
